+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biopsy Devices Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Biopsy Devices Market by Product Type, Application, End User - Global Forecast to 2030- Product Image
Sale

Biopsy Devices Market by Product Type, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6083646
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biopsy Devices Market grew from USD 10.46 billion in 2024 to USD 11.61 billion in 2025. It is expected to continue growing at a CAGR of 10.91%, reaching USD 19.48 billion by 2030.

Setting the Stage for Biopsy Device Market Evolution

The biopsy devices market is at a pivotal juncture, driven by mounting clinical demand for minimally invasive diagnostic procedures and an accelerating pace of technological innovation. As healthcare providers seek to enhance procedural accuracy and patient comfort, device manufacturers are responding with an expanded portfolio of offerings. These advancements are reshaping the diagnostic landscape across oncology, cardiology, neurology, and other specialty areas where precision tissue sampling is critical.

In this evolving environment, stakeholders must navigate a complex array of clinical protocols, regulatory frameworks, and reimbursement landscapes. Evolving patient demographics, increasing awareness of early disease detection, and the integration of imaging modalities are reshaping clinical workflows. Device developers are focusing on ergonomics, safety features, and connectivity, aligning product roadmaps with the needs of interventional radiologists, surgeons, and pathologists alike.

This executive summary distills key trends, market drivers, and actionable insights to inform strategic planning. By examining transformative shifts, regulatory impacts, segmentation dynamics, regional growth patterns, and competitive positioning, this report offers a comprehensive blueprint for decision-makers seeking to capitalize on the opportunities unfolding in the biopsy devices arena.

Emerging Innovations Reshaping Biopsy Practices

Over the past several years, the biopsy device landscape has undergone a series of transformative shifts that are redefining clinical practice. The convergence of advanced imaging modalities, such as real-time ultrasound and MRI-guided systems, with precision needle technologies is streamlining procedures and reducing patient discomfort. Artificial intelligence and machine learning algorithms are augmenting image interpretation, enabling more targeted sampling and minimizing the need for repeat procedures.

At the same time, the rise of robotic platforms and automated needle deployment systems is enhancing operator control and consistency. These innovations address longstanding challenges in manual sampling techniques, offering high-accuracy targeting even in anatomically complex or difficult-to-access lesions. Simultaneously, the push for single-use disposables and integrated safety mechanisms is mitigating infection risks and supporting stringent regulatory compliance.

Collectively, these disruptive developments are expanding the addressable market, as clinicians embrace next-generation solutions that deliver enhanced precision, reproducibility, and workflow efficiency. The ripple effects extend across manufacturers, healthcare providers, and payers, catalyzing new partnerships, investment rounds, and product lifecycle strategies.

Navigating the 2025 United States Tariff Landscape

In 2025, the introduction of revised tariffs on medical devices in the United States has introduced a new layer of complexity for global suppliers and domestic distributors. These measures, targeting import duties on equipment and component parts, have increased landed costs and pressured existing margin structures. Organizations that rely heavily on cross-border supply chains face the imperative to reassess supplier portfolios and explore cost mitigation strategies.

In response, many manufacturers are accelerating localization efforts, shifting assembly operations closer to key end-markets, or diversifying component sourcing across multiple geographies. Buyers are renegotiating long-term contracts and exploring value-based procurement models to offset tariff-induced price escalations. Meanwhile, partnerships with logistics providers are being reexamined to streamline customs clearance, minimize demurrage fees, and maintain inventory continuity.

Although these shifts present short-term headwinds, they also create opportunities for agile players to differentiate through supply chain resilience. Organizations that proactively adapt to the tariff environment by optimizing production footprints, enhancing supplier collaboration, and leveraging data analytics to forecast cost impacts will emerge stronger in a landscape marked by geopolitical uncertainties and evolving trade policies.

In-Depth Segmentation Reveals Targeted Growth Opportunities

A nuanced understanding of market segmentation reveals distinct pockets of growth and competitive intensity. The product type dimension encompasses Core Needle solutions available in both automatic and semi-automatic formats, alongside Endoscopic systems featuring flexible and rigid designs. Fine Needle Aspiration devices bifurcate into aspiration-based and manual instruments, while Vacuum Assisted platforms split between console-based workstations and portable handheld units.

Application-wise, breast interventions dominate demand, with diagnostic and screening modalities driving widespread adoption of specialized syringes and integrated imaging needles. Kidney procedures bifurcate into open surgical and percutaneous approaches, necessitating devices optimized for access depth and tract stability. Liver biopsy tools designed for percutaneous and transjugular access require tailored needle tip geometries and safety locks to mitigate hemorrhagic risk. In pulmonary applications, transbronchial and transthoracic techniques demand precision guidance and needle steerability, whereas prostate sampling relies on transperineal and transrectal routes that integrate with ultrasound navigation systems.

Across these clinical settings, the end user hierarchy spans ambulatory surgical centers, clinics, diagnostic laboratories, and hospitals. Each channel places unique demands on sterilization protocols, device throughput, and cost structures. By aligning product roadmaps with the workflows and purchasing models of these distinct end users, manufacturers can optimize market penetration and foster deeper customer partnerships.

Regional Dynamics Driving Market Trajectories

Geographic performance in the biopsy devices market reflects diverse regulatory, economic, and clinical landscapes. In the Americas, robust healthcare infrastructure and well-established reimbursement frameworks have driven widespread uptake of advanced needle technologies and imaging-guided platforms. The region’s emphasis on outpatient care has propelled growth in ambulatory surgical centers and specialty clinics, creating demand for portable devices and streamlined procedural kits.

Europe, Middle East & Africa present a mosaic of market dynamics, where regulatory harmonization under initiatives like CE marking coexists with country-specific reimbursement criteria. Western European markets prioritize integrated workflow solutions supported by hospital networks, while emerging economies in the Middle East and Africa are accelerating infrastructure investments to improve diagnostic capacity. Public-private partnerships and government health programs are expanding access to minimally invasive diagnostics, fueling demand for cost-efficient, single-use biopsy systems.

In Asia-Pacific, rapid urbanization, rising healthcare expenditure, and a growing emphasis on early cancer detection are driving double-digit growth in key markets. National screening initiatives and private hospital expansions are elevating procedural volumes for liver, lung, and prostate biopsies. Domestic manufacturers are gaining traction by tailoring devices to regional clinical practices and price sensitivities, while global players are forging joint ventures to navigate local regulatory pathways.

Competitive Landscape Highlights Leading Biopsy Device Providers

The competitive landscape in the biopsy devices sector features an array of global leaders and innovative challengers. Market pioneers have leveraged extensive clinical trial data, robust distribution networks, and strategic alliances to cement their positions. These incumbents focus on iterative enhancements to needle design, integration of imaging compatibility, and service offerings spanning training, support, and warranty coverage.

At the same time, specialized device developers are differentiating through disruptive technologies such as robotic navigation modules, RFID-enabled traceability systems, and eco-friendly materials. These players are capitalizing on niche clinical applications, forging co-development agreements with academic research centers, and participating in early access programs to validate efficacy and safety.

Collaborations between device manufacturers and medical software firms are also gaining momentum, as digital platforms enable remote procedure planning, real-time analytics, and post-procedure outcome tracking. This convergence of hardware and software underscores a broader shift toward end-to-end solutions that enhance procedural efficiency, reduce complication rates, and support value-based healthcare models.

Strategic Imperatives for Industry Leadership

Industry leaders should pursue a multi-pronged strategy to secure sustainable growth. First, investing in modular design platforms will enable rapid customization of needle assemblies and imaging integrations, addressing diverse clinical protocols without protracted development cycles. Second, establishing regional manufacturing or assembly hubs will mitigate tariff exposures and enhance supply chain resilience in volatile trade environments.

Third, forging partnerships with digital health and artificial intelligence firms can expedite the development of analytics-driven guidance systems, elevating procedural accuracy and creating differentiated service offerings. Fourth, engaging in proactive regulatory dialogues and participating in consensus standards committees will streamline product approval timelines and align device specifications with emergent safety mandates.

Finally, expanding presence in high-growth markets through targeted channel partnerships and localized training programs will build customer loyalty and drive adoption. By coupling these strategic initiatives with robust market intelligence and agile operational models, organizations can navigate evolving dynamics and capture market share in a competitive landscape.

Robust Methodological Framework Underpinning Insights

This analysis is grounded in a rigorous, multi-stage research methodology that integrates both primary and secondary data sources. Expert interviews with key opinion leaders, senior clinicians, and procurement executives provided qualitative insights into clinical workflows, unmet needs, and purchasing behaviors. These firsthand perspectives were triangulated with organizational filings, peer-reviewed publications, and patent databases to validate competitive positioning and technology trends.

Secondary research encompassed analysis of regulatory filings, import-export data, and reimbursement policy documents to quantify market influences and tariff impacts. A proprietary database of product pipelines, clinical trial registries, and merger and acquisition activity informed the assessment of innovation trajectories and strategic alliances. Data integrity was ensured through cross-verification by an editorial review board and a final validation workshop with industry stakeholders.

This comprehensive approach underpins the credibility of the findings, ensuring that stakeholders can rely on the insights to guide strategic planning, investment decisions, and product development roadmaps.

Synthesis of Market Insights and Forward Outlook

The biopsy devices market stands at the intersection of clinical innovation, regulatory evolution, and shifting economic paradigms. Enhanced imaging integration, automation, and digital analytics are converging to elevate procedural precision and improve patient outcomes. At the same time, trade policies and tariff revisions are reshaping supply chain strategies, compelling organizations to adapt or risk margin erosion.

Segmentation analysis highlights targeted growth pockets across product types, clinical applications, and end-user channels, enabling manufacturers to align R&D investments and commercialization efforts with high-value niches. Regional insights underscore the necessity of tailored market entry strategies that account for reimbursement landscapes, infrastructure maturity, and local partnerships.

In this dynamic environment, industry leaders who invest in agile innovation, supply chain resilience, and strategic collaborations will be best positioned to capture emerging opportunities. The convergence of hardware advancements and digital capabilities heralds a new era for minimally invasive diagnostics, one in which informed decision-making and proactive adaptation are paramount.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Core Needle
      • Automatic
      • Semi Automatic
    • Endoscopic
      • Flexible
      • Rigid
    • Fine Needle Aspiration
      • Aspiration
      • Manual
    • Vacuum Assisted
      • Console Based
      • Handheld
  • Application
    • Breast
      • Diagnostic
      • Screening
    • Kidney
      • Open
      • Percutaneous
    • Liver
      • Percutaneous
      • Transjugular
    • Lung
      • Transbronchial
      • Transthoracic
    • Prostate
      • Transperineal
      • Transrectal
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Diagnostic Laboratories
    • Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Olympus Corporation
  • Cook Incorporated
  • Argon Medical Devices, Inc.
  • Merit Medical Systems, Inc.
  • Teleflex Incorporated
  • Medtronic plc
  • Ethicon Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopsy Devices Market, by Product Type
8.1. Introduction
8.2. Core Needle
8.2.1. Automatic
8.2.2. Semi Automatic
8.3. Endoscopic
8.3.1. Flexible
8.3.2. Rigid
8.4. Fine Needle Aspiration
8.4.1. Aspiration
8.4.2. Manual
8.5. Vacuum Assisted
8.5.1. Console Based
8.5.2. Handheld
9. Biopsy Devices Market, by Application
9.1. Introduction
9.2. Breast
9.2.1. Diagnostic
9.2.2. Screening
9.3. Kidney
9.3.1. Open
9.3.2. Percutaneous
9.4. Liver
9.4.1. Percutaneous
9.4.2. Transjugular
9.5. Lung
9.5.1. Transbronchial
9.5.2. Transthoracic
9.6. Prostate
9.6.1. Transperineal
9.6.2. Transrectal
10. Biopsy Devices Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Diagnostic Laboratories
10.5. Hospitals
11. Americas Biopsy Devices Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Biopsy Devices Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Biopsy Devices Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Hologic, Inc.
14.3.2. Becton, Dickinson and Company
14.3.3. Boston Scientific Corporation
14.3.4. Olympus Corporation
14.3.5. Cook Incorporated
14.3.6. Argon Medical Devices, Inc.
14.3.7. Merit Medical Systems, Inc.
14.3.8. Teleflex Incorporated
14.3.9. Medtronic plc
14.3.10. Ethicon Inc.
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. BIOPSY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. BIOPSY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. BIOPSY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOPSY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOPSY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPSY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPSY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPSY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPSY DEVICES MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPSY DEVICES MARKET SIZE, BY SEMI AUTOMATIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPSY DEVICES MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPSY DEVICES MARKET SIZE, BY RIGID, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BIOPSY DEVICES MARKET SIZE, BY ASPIRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BIOPSY DEVICES MARKET SIZE, BY MANUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CONSOLE BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HANDHELD, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BIOPSY DEVICES MARKET SIZE, BY SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BIOPSY DEVICES MARKET SIZE, BY OPEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TRANSJUGULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TRANSBRONCHIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TRANSTHORACIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TRANSPERINEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BIOPSY DEVICES MARKET SIZE, BY TRANSRECTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BIOPSY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BIOPSY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BIOPSY DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BIOPSY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES BIOPSY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. CANADA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. CANADA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 77. CANADA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 78. CANADA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 79. CANADA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 80. CANADA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 82. CANADA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 83. CANADA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 84. CANADA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 85. CANADA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 86. CANADA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. MEXICO BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 89. MEXICO BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 90. MEXICO BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 92. MEXICO BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. MEXICO BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 94. MEXICO BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 95. MEXICO BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 96. MEXICO BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 97. MEXICO BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 98. MEXICO BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. BRAZIL BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA BIOPSY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. GERMANY BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. GERMANY BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 150. GERMANY BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 151. GERMANY BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 153. GERMANY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 155. GERMANY BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 156. GERMANY BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 157. GERMANY BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 158. GERMANY BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 159. GERMANY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. FRANCE BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. FRANCE BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 162. FRANCE BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 163. FRANCE BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 164. FRANCE BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 165. FRANCE BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 167. FRANCE BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 168. FRANCE BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 169. FRANCE BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 170. FRANCE BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 171. FRANCE BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 179. RUSSIA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 180. RUSSIA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 181. RUSSIA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 182. RUSSIA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 183. RUSSIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. ITALY BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. ITALY BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 186. ITALY BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 187. ITALY BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 188. ITALY BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 189. ITALY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. ITALY BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 191. ITALY BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 192. ITALY BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 193. ITALY BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 194. ITALY BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 195. ITALY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SPAIN BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 198. SPAIN BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 199. SPAIN BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 200. SPAIN BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 201. SPAIN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. SPAIN BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 203. SPAIN BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 204. SPAIN BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 205. SPAIN BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 206. SPAIN BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 212. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 213. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 215. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 216. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 217. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 218. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 223. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 224. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 225. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 227. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 228. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 229. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 230. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 234. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 235. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 236. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 240. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 242. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. DENMARK BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. DENMARK BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 246. DENMARK BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 247. DENMARK BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 248. DENMARK BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 249. DENMARK BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. DENMARK BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 251. DENMARK BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 252. DENMARK BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 253. DENMARK BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 254. DENMARK BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 255. DENMARK BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 268. QATAR BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. QATAR BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 270. QATAR BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 271. QATAR BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 272. QATAR BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 273. QATAR BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. QATAR BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 275. QATAR BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 276. QATAR BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 277. QATAR BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 278. QATAR BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 279. QATAR BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. FINLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. FINLAND BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 282. FINLAND BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 283. FINLAND BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 284. FINLAND BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 285. FINLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 286. FINLAND BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 287. FINLAND BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 288. FINLAND BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 289. FINLAND BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 290. FINLAND BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 291. FINLAND BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 300. SWEDEN BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 301. SWEDEN BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 302. SWEDEN BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 303. SWEDEN BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. NIGERIA BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. NIGERIA BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 306. NIGERIA BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 307. NIGERIA BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 308. NIGERIA BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 309. NIGERIA BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. NIGERIA BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 311. NIGERIA BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 312. NIGERIA BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 313. NIGERIA BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 314. NIGERIA BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 315. NIGERIA BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. EGYPT BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. EGYPT BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 318. EGYPT BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 319. EGYPT BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 320. EGYPT BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 321. EGYPT BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 322. EGYPT BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 323. EGYPT BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 324. EGYPT BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 325. EGYPT BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 326. EGYPT BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 327. EGYPT BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 328. TURKEY BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 329. TURKEY BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 330. TURKEY BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 331. TURKEY BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 332. TURKEY BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 333. TURKEY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. TURKEY BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 335. TURKEY BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 336. TURKEY BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 337. TURKEY BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 338. TURKEY BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 339. TURKEY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. ISRAEL BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 341. ISRAEL BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 342. ISRAEL BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 343. ISRAEL BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 344. ISRAEL BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 345. ISRAEL BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 346. ISRAEL BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 347. ISRAEL BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 348. ISRAEL BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 349. ISRAEL BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 350. ISRAEL BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 351. ISRAEL BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 352. NORWAY BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 353. NORWAY BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 354. NORWAY BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 355. NORWAY BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 356. NORWAY BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 357. NORWAY BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 358. NORWAY BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 359. NORWAY BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 360. NORWAY BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 361. NORWAY BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 362. NORWAY BIOPSY DEVICES MARKET SIZE, BY PROSTATE, 2018-2030 (USD MILLION)
TABLE 363. NORWAY BIOPSY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 364. POLAND BIOPSY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 365. POLAND BIOPSY DEVICES MARKET SIZE, BY CORE NEEDLE, 2018-2030 (USD MILLION)
TABLE 366. POLAND BIOPSY DEVICES MARKET SIZE, BY ENDOSCOPIC, 2018-2030 (USD MILLION)
TABLE 367. POLAND BIOPSY DEVICES MARKET SIZE, BY FINE NEEDLE ASPIRATION, 2018-2030 (USD MILLION)
TABLE 368. POLAND BIOPSY DEVICES MARKET SIZE, BY VACUUM ASSISTED, 2018-2030 (USD MILLION)
TABLE 369. POLAND BIOPSY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 370. POLAND BIOPSY DEVICES MARKET SIZE, BY BREAST, 2018-2030 (USD MILLION)
TABLE 371. POLAND BIOPSY DEVICES MARKET SIZE, BY KIDNEY, 2018-2030 (USD MILLION)
TABLE 372. POLAND BIOPSY DEVICES MARKET SIZE, BY LIVER, 2018-2030 (USD MILLION)
TABLE 373. POLAND BIOPSY DEVICES MARKET SIZE, BY LUNG, 2018-2030 (USD MILLION)
TABLE 374. POLAND BIOPSY DEVICES MA

Companies Mentioned

The companies profiled in this Biopsy Devices market report include:
  • Hologic, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Olympus Corporation
  • Cook Incorporated
  • Argon Medical Devices, Inc.
  • Merit Medical Systems, Inc.
  • Teleflex Incorporated
  • Medtronic plc
  • Ethicon Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 11.61 Billion
Forecasted Market Value ( USD ) by 2030 $ 19.48 Billion
Compound Annual Growth Rate10.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Robotic Biopsy Devices Market by Product Type, Technology, Application, End User, Procedure Type - Global Forecast to 2030 - Product Image

Robotic Biopsy Devices Market by Product Type, Technology, Application, End User, Procedure Type - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Breast Biopsy Device Market by Product Type, Technique, End User, Application - Global Forecast to 2030 - Product Image

Breast Biopsy Device Market by Product Type, Technique, End User, Application - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
Bronchial Biopsy Devices Market Size, Share and Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), and Region 2024-2030 - Product Image

Bronchial Biopsy Devices Market Size, Share and Trends Analysis Report by Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Biopsy Devices Market by Product (Core Needle Biopsy (Automatic, Disposable), Technology (Ultrasound,Stereotactic), Application (Oncology, Gastroenterology, Bone & Bone Marrow Biopsy), End User (Diagnostic Imaging Centres) - Global Forecast to 2030 - Product Image

Biopsy Devices Market by Product (Core Needle Biopsy (Automatic, Disposable), Technology (Ultrasound,Stereotactic), Application (Oncology, Gastroenterology, Bone & Bone Marrow Biopsy), End User (Diagnostic Imaging Centres) - Global Forecast to 2030

  • Report
  • 504 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.